Your browser doesn't support javascript.
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk.
Klein, Christine; Borsche, Max; Balck, Alexander; Föh, Bandik; Rahmöller, Johann; Peters, Elke; Knickmann, Jan; Lane, Miranda; Vollstedt, Eva-Juliane; Elsner, Susanne A; Käding, Nadja; Hauswaldt, Susanne; Lange, Tanja; Hundt, Jennifer E; Lehrian, Selina; Giese, Julia; Mischnik, Alexander; Niemann, Stefan; Maurer, Florian; Homolka, Susanne; Paulowski, Laura; Kramer, Jan; Twesten, Christoph; Sina, Christian; Gillessen-Kaesbach, Gabriele; Busch, Hauke; Ehlers, Marc; Taube, Stefan; Rupp, Jan; Katalinic, Alexander.
  • Klein C; Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Borsche M; Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Balck A; Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Föh B; Department of Neurology, University of Lübeckand and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Rahmöller J; Institute of Nutritional Medicine, University of Lübeck, Lübeck, Germany.
  • Peters E; Department of Medicine I, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Knickmann J; Institute of Nutritional Medicine, University of Lübeck, Lübeck, Germany.
  • Lane M; Department of Anesthesiology and Intensive Care, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Vollstedt EJ; Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.
  • Elsner SA; Institute of Virology and Cell Biology, University of Lübeck, Lübeck, Germany.
  • Käding N; Institute of Virology and Cell Biology, University of Lübeck, Lübeck, Germany.
  • Hauswaldt S; Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Lange T; Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.
  • Hundt JE; Department of Infectious Diseases and Microbiology, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Lehrian S; Department of Infectious Diseases and Microbiology, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Giese J; Department of Rheumatology and Clinical Immunology, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Mischnik A; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
  • Niemann S; Institute of Nutritional Medicine, University of Lübeck, Lübeck, Germany.
  • Maurer F; Institute of Nutritional Medicine, University of Lübeck, Lübeck, Germany.
  • Homolka S; Health Protection Authority, Lübeck, Germany.
  • Paulowski L; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Kramer J; German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
  • Twesten C; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Sina C; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Gillessen-Kaesbach G; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Busch H; Institute of Virology and Cell Biology, University of Lübeck, Lübeck, Germany.
  • Ehlers M; LADR Laboratory Group Dr. Kramer & Colleagues, Geesthacht, Germany.
  • Taube S; Perfood GmbH, Lübeck, Germany.
  • Rupp J; Institute of Nutritional Medicine, University of Lübeck, Lübeck, Germany.
  • Katalinic A; University of Lübeck, Lübeck, Germany.
Sci Adv ; 8(15): eabm5016, 2022 Apr 15.
Article in English | MEDLINE | ID: covidwho-1794539
ABSTRACT
With newly rising coronavirus disease 2019 (COVID-19) cases, important data gaps remain on (i) long-term dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates in fixed cohorts (ii) identification of risk factors, and (iii) establishment of effective surveillance strategies. By polymerase chain reaction and antibody testing of 1% of the local population and >90,000 app-based datasets, the present study surveilled a catchment area of 300,000 inhabitants from March 2020 to February 2021. Cohort (56% female; mean age, 45.6 years) retention was 75 to 98%. Increased risk for seropositivity was detected in several high-exposure groups, especially nurses. Unreported infections dropped from 92 to 29% during the study. "Contact to COVID-19-affected" was the strongest risk factor, whereas public transportation, having children in school, or tourism did not affect infection rates. With the first SARS-CoV-2 cohort study, we provide a transferable model for effective surveillance, enabling monitoring of reinfection rates and increased preparedness for future pandemics.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.abm5016

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.abm5016